Home >Newsletters >December 2001
 
ASA NEWSLETTER
 
 
December 2001
Volume 65
Number 12
   
2001: Not Shoes, Nor Ships, Nor Sealing Wax

Michael Scott, J.D., Director
Governmental and Legal Affairs


The December NEWSLETTER offers an appropriate opportunity to heed the Walrus’ advice to the Carpenter in Alice in Wonderland — that the time has come to talk of many things. Not only has the first year of the new millennium brought us an international conflict of yet unmeasurable proportions, but in many ways, it may also prove to have been a seminal year for ASA and its members.

I have no special qualification to bring greater understanding to the cataclysmic international events that have beset us, but I have found myself this year at ground zero of some events of more direct consequence to the specialty. Those include not shoes, nor ships, nor sealing wax but the less lyrical subjects of supervision, physician work and pain medicine. No alliteration there, but much substance. A prefatory note, however: The views expressed in the article are mine and not necessarily the ASA officers or its governing House of Delegates.

The Bush Rule
In retrospect, one justice of the United States Supreme Court is responsible for the fact that we may continue to work within the terms of scientific rationality in addressing the nurse anesthetist supervision issue. For four long years, ASA had fought the political forces within the Clinton administration, which was committed to federal abandonment of the Medicare supervision requirement. On January 18, with publication of the Clinton final rule, we had lost. Not only had we failed to change that administration’s mind on the safety issues inherent in its proposed rule, we had failed to convince Congress to get involved. We had succeeded in tying the final rule up at the Office of Management and Budget for many months, but in the end — the very end — then Health and Human Services (HHS) Secretary Donna Shalala was able to break the rule free and into print.

Fortuitously, however, the Supreme Court had decided, by a one-vote margin, that George W. Bush and not Al Gore had won Florida: I know, that is not what the court said, but that was the effect of its decision just the same. And so, on January 20, 2001, a new day dawned for all opponents, including ASA, of Clinton rules rushed into print in the final days of the last administration. In effect, a new judge and jury on the anesthesia safety issue came to town, both at HHS and in the White House.

What emerged from the Bush administration on the supervision issue was a compromise. ASA had been arguing for an outcomes study to be completed before any decision was reached on the federal rule. The American Association of Nurse Anesthetists (AANA) opposed any delay and supported turning the issue over to the states without further scientific analysis. The Bush Administration in its July 5 proposed rule borrowed from both houses, retaining the federal supervision requirement but giving state governors the choice to opt-out of the requirement to the extent consistent with state law.

ASA embraced the proposed rule; AANA opposed the rule, but said that if the administration decided to finalize it, then an automatic opt out should be given all states that currently have no supervision requirement. When you think about that latter proposal (and I get paid to think about such things), this is simply the Clinton rule in disguise. Fortunately, the Bush Administration saw through the disguise and rejected the idea.

AANA publicists have muttered darkly in print about the July 5 rule having resulted from a “political deal” between ASA and the White House. Leaving entirely aside the fact that politics for better or worse is what this city is all about (why else would have ASA and AANA hired all those lobbyists?), a more accurate characterization of what happened is that our ability to receive a fair hearing at HHS and the White House was enhanced by our relatively stronger support than AANA for GOP candidates in the 2000 and prior elections and by our early support in 2001 for the White House views on patient protection liability issues. We also were measurably aided by urgings of key Senators and Representatives, on both sides of the aisle, who believed that a real anesthesia patient safety issue was at stake and were willing to stand up and be counted.

Not that politics were not involved in the Clinton administration’s decision to eliminate supervision, of course. Why else would that administration in 1999 pluck the nurse anesthetist supervision issue from a host of other important proposed changes in the originally proposed 1997 rule and move it alone toward finalization? Why else would the administration in 1997 say that it was moving from process-oriented hospital standards to result-oriented standards, and then finalize a supervision rule in 2001 that gives not the slightest hint as to what those latter standards are to be? And why else would the administration, in justification of the final rule, simply say that its “view” of the importance of anesthesiologist supervision had changed over the past decade, without citing any supporting scientific data and instead requiring that its opponents prove that the rule change was unsafe?

So much for HHS’ statutory responsibility to protect the health and safety of Medicare beneficiaries. Fortunately for Medicare patients, the Bush administration adopted a more reasoned approach.

With publication of the final rule on November 13, the supervision issue now moves to the gubernatorial offices of the various states. It is not reasonable to assume that governors in those states where physician participation is not mandated will automatically seek an opt-out — far from it. A little known fact is that the Medicare supervision rule predates virtually all state legislation or regulations on this subject and as a practical matter has set the minimum standard for all hospitals in this country, no matter what state law says.

Now state governments must suddenly examine the wisdom of physician supervision for themselves: What for the states in the past three decades has been essentially an academic exercise now becomes directly significant to their resident senior citizens who previously were protected by the federal rule everywhere. Given the fact that four out of five surveyed senior citizens have repeatedly said they want a physician involved in their anesthesia care, a new political reality emerges at the state level. We anticipate that the governors, not to speak of the legislatures, will approach this issue with the political and scientific caution it deserves.

It will not be sufficient, as it has never been sufficient, for us merely to repeat the mantra, “Anesthesiology is the practice of medicine.” ASA members may truly believe the truth of that statement, but in the legislative-regulatory arena, it is necessary to prove the correctness of that statement in the face of competing claims by the nurses to the contrary. Nor is it sufficient merely to rely on the fact that senior citizens want a physician involved in their anesthesia care, especially when that added oversight costs them no money. Of course they do, but we must go further and establish that there is good scientific reason for them to want that kind of oversight.

My impression from the 2001 Annual Meeting is that the ASA leadership is prepared to commit resources to help the components deal with gubernatorial opt-out proposals. That is all well and good, but we must bear in mind that the supervision issue is now a state matter, which means that the components are going to be required to take the lead. In the last analysis, whether the components are up to that task depends upon whether their members are committed to supporting them. In other words, the chickens are coming home to roost. Is the henhouse open and heated?


“Anesthesiology is the practice of medicine.’ ASA members may truly believe the truth of that statement, but in the legislative-regulatory arena, it is necessary to prove the correctness of that statement in the face of competing claims by the nurses to the contrary.”



Anesthesia Work Values

Despite our early optimism, this issue of the NEWSLETTER carries the word that we have failed in our efforts to gain an increase in anesthesia work values under the 2002 Medicare Fee Schedule. This, despite the fact that three separate analyses of anesthesia work — completed at the request of the American Medical Association (AMA)-Specialty Society Relative Value Update Committee (RUC) — disclosed that those values are understated by varying percentages approximating 25 percent.

To understand this result, one must understand the rules under which ASA was forced to operate. First, and most importantly, reappraisal of work values under the Fee Schedule is a zero-sum game. If anesthesia gains an increase in work values, all other specialties pay the price in the form of decreased work values. Thomas A. Scully, Centers for Medicare & Medicaid Services (CMS) Administrator, was recently quoted as saying he loved the RUC process: “Given the choice of having physicians get in a room and fight with each other over what should be done or me get in the room and fight over what should be done, I’ll always pick them.” RUC decisions are merely advisory to CMS but, consistent with Administrator Scully’s outlook, CMS rarely disagrees with RUC.

Second, we must bear in mind that anesthesia work values were increased by 22.76 percent just five years ago, and then only after a long and bloody battle within RUC. A fair assumption is that many current RUC members took this fact into account when considering a similar increase this time around. Some RUC members also have the perception, whether fair or unfair, that much of the anesthesia care teamwork is done by nurse anesthetists and not by the medically directing anesthesiologist. Along this same line, we also must remember that anesthesiologists are regularly reported by AMA and the trade press as among the highest paid physicians. Those on RUC representing lower paid specialties can read these reports just as easily as we can, and make their own individual judgments as to the comparative relative work effort involved between the two specialties.

Third, we were caught up at CMS in an unanticipated development: the looming access crisis that could be generated by a projected negative update in the 2002 Fee Schedule conversion factor (see the article by Karin Bierstein on page 31). In the face of this crisis, it simply was not reasonable to expect that CMS would exacerbate the problem for all other specialties by overriding the RUC anesthesia recommendation — or more accurately, “no recommendation” — thereby increasing the negative update even more.

There is no question but that between the RUC and the CMS staff, ASA was jerked around pretty badly in the process. As one hurdle was overcome, another was erected by RUC. CMS positions on various sub-issues seemed to come and go with the wind. After many months of this treatment, it simply became clear that no matter what evidence ASA presented — no matter how compelling — there was no serious interest abroad in increasing anesthesia work values.

ASA is aware of considerable anecdotal evidence that increasing numbers of anesthesiologists are electing to move from, or not to enter, geographic areas with heavy Medicare populations. Medicare anesthesia fees represent about 39 percent of private payment levels; for all physicians, they are more than 76 percent. Most anesthesiologists work under formal or informal hospital contracts that compel them to treat all patients who present themselves in the institution without regard to insurance payer. It takes no genius to figure out that for some parts of the country, RUC’s nondecision of anesthesia work values will significantly contribute to an anesthesia access crisis, a crisis already forming as a result of previous declines in anesthesia residency positions.

RUC members, though not apparently CMS staff, claim difficulty in evaluating anesthesia work because the method of anesthesia reimbursement under the Fee Schedule is different from that of virtually all other specialties: anesthesiologists and nurse anesthetists are reimbursed on the basis of complexity (basic) units and time units multiplied by a conversion factor, whereas other specialties are reimbursed on the basis of relative value units multiplied by a different conversion factor. Although it is mathematically relatively simple to work back and forth between the two systems, there appears to be an underlying and undying suspicion at RUC that apples are not being compared to apples.

RUC has appointed a work group to study whether anesthesia reimbursement can be integrated into the Fee Schedule system applicable to all other disciplines. This is an enormously complicated subject, essentially because unlike other physicians, anesthesiologists do not control the time devoted to a particular procedure, and a fair system of averaging anesthesia time (which would be necessary in any integration method) is difficult to conceive. It is worth noting in passing that Blue Cross/Blue Shield of Michigan, which a few years ago went to average anesthesia time, recently abandoned that methodology and returned to the base plus time system. Also worth noting is the fact that academic centers which traditionally report longer time periods because of the teaching process almost certainly could be seriously disadvantaged by a system based on average time.

The good news on this subject, if there is any, is that CMS has agreed to pursue the subject of a fair value of anesthesia work next year; but if it turns out that CMS is willing to move only on RUC recommendation, revaluation of anesthesia work may have to wait until the integration concept is further explored at RUC. Certainly, Administrator Scully’s remarks as quoted above would suggest that this is the most likely result. Smarter people than me on the ASA Committee on Economics are wrestling with these issues, and we must simply hope that they can find a formula for accommodation with RUC. Never forget, however, that this is a zero-sum game, no matter what the anesthesia reimbursement methodology.

Pain Management
Over the past year, ASA has been attacked — unfairly I think — for its perceived lack of attention to pain management issues under the Medicare program. Most recently, one pain management group claimed sole credit for the inclusion of nine new codes on the Medicare-approved list for performance in ambulatory surgical centers when in fact ASA had been the leader of a coalition for many months prior to that event directed to the very same end.

The fact is that ASA has been most active on this front, not only in connection with Medicare treatment of pain procedures, but as a part of the Current Procedural Terminology™ and RUC processes by which new codes are defined and valued for Medicare reimbursement purposes. It is also a fact, however, that ASA must pay attention to the rules and policies under which all its members practice, and there is a limit to the human and financial resources that ASA can commit to reimbursement issues that confront us each year. In those circumstances, it is almost inevitable that some subspecialty practitioners, including pain practitioners and some critical care physicians, may feel that their problems do not gain the attention they deserve.

For some years, the ASA Committee on Economics has designated individual committee members to act as liaisons to subspecialty groups and here in the Washington Office. There is no sense that certain issues are more important than others. Certainly, because the vast majority of ASA members continue to provide surgery-related general or regional anesthesia in the operating room, our expertise on CMS policies related to that mode of practice is deeper than for subspecialty efforts, but there is a renewed recognition that we must be more proactive in the latter realms. This recognition is both self-generated and a result of directives from the ASA leadership.

It is perhaps important for subspecialties to bear in mind that access to decision-makers on all anesthesia-related issues is facilitated by the fact that ASA has a seat at the table at CPT, RUC, AMA and, less formally, at CMS and in Congress. We work regularly with other specialties with which we share common interests on a variety of legislative and regulatory issues. After AMA, ASA sponsors the largest political action committee in American medicine, and we have worked with CMS staff on a host of anesthesia issues since virtually the inception of the Medicare program. ASA leadership has made it clear that these resources and opportunities are to be made available for all disciplines of the practice, and we expect to honor that commitment.



    Michael Scott, J.D., oversees the federal, state, regulatory, lobbying and legal activities in the ASA Washington Office.


return to top


 


FEATURES

ARTICLES

DEPARTMENTS

The views expressed herein are those of the authors and do not necessarily represent or reflect the views, policies or actions of the American Society of Anesthesiologists.

NL Archives

Information for Authors